News | 30. July 2023

Bioavailability assessment of HIPPOCOR®

In 2023, síbiotech, in cooperation with the University of Latvia and the Institute of Food Safety, Animal Health and Environment “BIOR” conducted a bioavailability assessment of HIPPOCOR®, the sea buckthorn seed lipid extract.

Five healthy subjects were recruited in this pilot assessment. Blood samples were taken from each subject before administration, after 1, 6, 24 and 31 hours, respectively. During this assessment, study subjects avoided consuming any lipid-containing products.

The assessment results showed that before and 6 to 24 hours after administration of HIPPOCOR ®, there was an increase in unsaturated fatty acid levels by 10% and a decrease in saturated acid by 5%.

With this assessment, we have noticed that using supercritical fluid extraction to obtain fat soluble bioactive compounds out of plant matrices, it is possible to obtain fatty acids in their natural chemical form available for the human body to absorb in the blood and provide health support.

It is planned to continue the trial at the end of 2023.

Lipid extract of sea buckthorn seeds and blood fatty acid profile, Kristaps Erglis et al Medicina (Kaunas) 2023;59 (Supplement 1):40